Konicef S 250mg/125mg Injection
Marketer
Kanraxy Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Konicef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), sold as Konicef S, combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this combination medication requires adherence to the prescribed schedule. Complete the full course of treatment, even with symptom improvement, to prevent treatment failure. Discontinuing prematurely may reduce its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening side effects require immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your physician about all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential drowsiness. While driving ability is usually unaffected, avoid driving if drowsiness or dizziness occurs. Rest, a nutritious diet, and adequate hydration support recovery. Monitoring through lab tests may be necessary to assess treatment response.
Uses of Konicef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Konicef S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Konicef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Konicef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Konicef S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, the components of Konicef S 250mg/125mg Injection, act synergistically. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Konicef S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Konicef S, 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Konicef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Konicef S 250mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Konicef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Konicef S 250mg/125mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alterations for Konicef S 250mg/125mg Injection are generally not advised for those with mild or moderate liver dysfunction.
What if you forget to take Konicef S 250mg/125mg Injection :
Omit a Konicef S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Konicef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently